Advertisement.

CYTO Projected Dividend Yield

Ord Par $ 0.002 (New)/Altamira Therapeutics Ltd ( NASDAQ : CYTO )

Altamira Therapeutics is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company focused on developing therapeutics that address unmet medical needs. Co. has been focusing on the development of therapeutics for inner ear disorders: Keyzilen® (AM-101) in acute inner ear tinnitus, Sonsuvi® (AM-111) in acute inner ear hearing loss and AM-125 in acute peripheral vertigo. Co. has launched Bentrio™, a drug free medical device for protection against airborne allergens and viruses in selected European markets. Further, Co. has entered the field of RNA delivery.

20 YEAR PERFORMANCE RESULTS

CYTO Dividend History Detail
CYTO Dividend News
CYTO Competitors News

# of Shares: 0

Closing Price: 0.43

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000